Werewolf Therapeutics logo

Werewolf Therapeutics Share Price (NASDAQ: HOWL)

$1.32

-0.07

(-5.04%)

Last updated on

Check the interactive Werewolf Therapeutics Stock chart to analyse performance

Werewolf Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.32
    Today's High:$1.37

    Day's Volatility :3.65%

  • 52 Weeks Low:$0.60
    52 Weeks High:$4.18

    52 Weeks Volatility :85.77%

Werewolf Therapeutics Stock Returns

PeriodWerewolf Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
10.0%
3.6%
0.0%
6 Months
15.79%
-7.7%
0.0%
1 Year
-35.61%
-12.6%
0.0%
3 Years
-78.18%
9.5%
-4.7%

Werewolf Therapeutics Inc Key Stats

Check Werewolf Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.39
Open
$1.36
Today's High
$1.37
Today's Low
$1.32
Market Capitalization
$63.6M
Today's Volume
$138.3K
52 Week High
$4.18
52 Week Low
$0.595
Revenue TTM
$0.0
EBITDA
$-71.3M
Earnings Per Share (EPS)
$-1.64
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-100.55%

Stock Returns calculator for Werewolf Therapeutics Stock including INR - Dollar returns

The Werewolf Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Werewolf Therapeutics investment value today

Current value as on today

₹66,395

Returns

₹33,605

(-33.6%)

Returns from Werewolf Therapeutics Stock

₹38,889 (-38.89%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Werewolf Therapeutics Stock

-39%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Werewolf Therapeutics Stock from India on INDmoney has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Werewolf Therapeutics Inc

  • Name

    Holdings %

  • RA Capital Management, LLC

    14.74%

  • Mpm Asset Management, LLC

    9.51%

  • MPM Oncology Impact Management LP

    5.31%

  • Bank of America Corp

    4.64%

  • BlackRock Inc

    3.69%

  • Vanguard Group Inc

    2.86%

Analyst Recommendation on Werewolf Therapeutics Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Werewolf Therapeutics(by analysts ranked 0 to 5 stars)

Werewolf Therapeutics Share Price Target

What analysts predicted

Upside of 442.93%

Target:

$7.17

Current:

$1.32

Werewolf Therapeutics share price target is $7.17, a slight Upside of 442.93% compared to current price of $1.32 as per analysts' prediction.

Werewolf Therapeutics Stock Insights

  • Price Movement

    In the last 1 year, HOWL stock has moved down by -38.9%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 1.14M → -49.0K (in $), with an average decrease of 147.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -20.4M → -17.98M (in $), with an average increase of 6.7% per quarter
  • HOWL vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 108.8%
  • HOWL vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 189.2%

Werewolf Therapeutics Technicals Summary

Sell

Neutral

Buy

Werewolf Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Werewolf Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Werewolf Therapeutics Inc logo
13.79%
15.79%
-35.61%
-78.18%
-91.8%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Werewolf Therapeutics Inc

Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
Organization
Werewolf Therapeutics
Employees
46
CEO
Dr. Daniel J. Hicklin Ph.D.
Industry
Services

Key Management of Werewolf Therapeutics Inc

NameTitle
Dr. Daniel J. Hicklin Ph.D.
Founder, CEO, President, Secretary & Director
Mr. Timothy W. Trost CPA
CFO, Treasurer & Assistant Secretary
Dr. Randi Isaacs M.D.
Chief Medical Officer
Dr. William Winston Ph.D.
Senior Vice President of Research
Dr. Chulani Karunatilake Ph.D.
Chief Technology Officer
Mr. Steven H. Bloom R.Ph.
Chief Business Officer

Important FAQs about investing in HOWL Stock from India :

What is Werewolf Therapeutics share price today?

Werewolf Therapeutics share price today is $1.32 as on at the close of the market. Werewolf Therapeutics share today touched a day high of $1.37 and a low of $1.32.

What is the 52 week high and 52 week low for Werewolf Therapeutics share?

Werewolf Therapeutics share touched a 52 week high of $4.18 and a 52 week low of $0.60. Werewolf Therapeutics stock price today i.e. is closed at $1.32, lower by 68.42% versus the 52 week high.

How to invest in Werewolf Therapeutics Stock (HOWL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Werewolf Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Werewolf Therapeutics Shares that will get you 1.1364 shares as per Werewolf Therapeutics share price of $1.32 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Werewolf Therapeutics Stock (HOWL) from India?

Indian investors can start investing in Werewolf Therapeutics (HOWL) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Werewolf Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Werewolf Therapeutics share’s latest price of $1.32 as on August 30, 2025 at 1:29 am IST, you will get 7.5758 shares of Werewolf Therapeutics. Learn more about fractional shares .

What are the returns that Werewolf Therapeutics has given to Indian investors in the last 5 years?

Werewolf Therapeutics stock has given -91.8% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?